Friday, November 21, 2008 - 1:11PM EST

General Interest Articles

1. Multiple myeloma: A review of the epidemiologic literature.

Author
Alexander DD; Mink PJ; Adami HO; Cole P; Mandel JS; Oken MM; Trichopoulos D;
Institution
Exponent Health Sciences Group, Exponent, Inc., Wood Dale, IL.
Journal
Int J Cancer. 2007;120 Suppl 12:40-61.
Abstract URL
Click here to view abstract

2. Patterns of Survival in Multiple Myeloma: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2003.

Author
Kristinsson SY; Landgren O; Dickman PW; Derolf AR; Bjorkholm M;
Institution
Division of Hematology, Department of Medicine, and Department of Medical Epidemiology and Biostatistics, Karolinska University Hospital and Institutet, Stockholm, Sweden; and Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
Journal
J Clin Oncol. 2007 Apr 9;.
Abstract URL
Click here to view abstract

3. Review Article: Multiple Myeloma and Inflammatory Bowel Disease.

Author
Reynolds GJ; Annis KA; de Villiers WJ;
Institution
University of Kentucky, Kentucky, USA.
Journal
Dig Dis Sci. 2007 Apr 10;.
Abstract URL
Click here to view abstract

4. Maintenance therapy in multiple myeloma.

Author
Mihelic R; Kaufman JL; Lonial S;
Institution
1Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA.
Journal
Leukemia. 2007 Mar 8;.
Abstract URL
Click here to view abstract

5. Defining Palliative Care, Cancer Without Pain, When to Contact Hospice, When to Treat Multiple Myeloma, Meaning of Physical Signs, Pneumonia at End-of-Life.

Author
Lamers WM;
Institution
, 9515 Seabreeze Terrace, Malibu, CA, 90265-2223, lamers@earthlink.net.
Journal
J Pain Palliat Care Pharmacother. 2007;21(1):85-90.
Abstract URL
Click here to view abstract

6. Multiple myeloma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Author
Harousseau JL; Dreyling M;
Institution
Department of Hematology, University Hospital Hotel-Dieu, Nantes, France.
Journal
Ann Oncol. 2008 May;19 Suppl 2:ii55-7.

7. Relationship between depth of response and outcome in multiple myeloma.

Author
Dingli D; Pacheco JM; Nowakowski GS; Kumar SK; Dispenzieri A; Hayman SR; Lacy MQ; Gastineau DA; Gertz MA;
Institution
Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Journal
J Clin Oncol. 2007 Nov 1;25(31):4933-7.
Abstract URL
Click here to view abstract

8. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

Author
Kyle RA; Rajkumar SV;
Institution
Division of Hematology, College of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. kyle.robert@mayo.edu
Journal
Hematol Oncol Clin North Am. 2007 Dec;21(6):1093-113, ix.
Abstract URL
Click here to view abstract

9. A retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patients.

Author
Jadu F; Lee L; Pharoah M; Reece D; Wang L;
Institution
Faculty of Dentistry, University of Toronto, Ontario, Canada. fatima.jadu@dentistry.utoronto.ca
Journal
Ann Oncol. 2007 Dec;18(12):2015-9. Epub 2007 Sep 5.
Abstract URL
Click here to view abstract

10. Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma.

Author
Kyle RA; Remstein ED; Therneau TM; Dispenzieri A; Kurtin PJ; Hodnefield JM; Larson DR; Plevak MF; Jelinek DF; Fonseca R; Melton LJ 3rd; Rajkumar SV;
Institution
Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA. kyle.robert@mayo.edu
Journal
N Engl J Med. 2007 Jun 21;356(25):2582-90.
Abstract URL
Click here to view abstract
Pages: 1 2 3